Puma Biotechnology, Inc.
Puma Biotechnology's (PBYI) Lowest Price: $1.6400 (on 05-11-2022)
Puma Biotechnology Inc Share Price USD0.0001
Puma Biotechnology
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe | Business Wire
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology, Inc. - SEC Filings - Annual Reports & Proxies
Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Fillable Online Puma biotechnology, inc. form s-1/a - Biotech Due Diligence Fax Email Print - pdfFiller
Puma Biotechnology, Inc. 2023 Q1 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
PUMA BIOTECHNOLOGY INC - COMMON STOCK 1 Full Quote | NetDania.com
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology, Inc. | CDISC
Puma Biotechnology, Inc. (NASD:PBYI) Seasonal Chart | Equity Clock
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2023
Puma Biotechnology Inc
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
Puma Biotechnology - Crunchbase Company Profile & Funding
PBYI Insider Trading Activity - Puma Biotechnology, Inc.
Puma Biotechnology, Inc. 2021 Q2 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading
